Treatment options for primary splenic low-grade non-Hodgkin's lymphomas

Clinical and Laboratory Haematology

Volumn 26, Issue 6, 2004, Pages 397-401

  Musteata, Vasile Gh ^a,b   Corcimaru, I T ^a,b   Iacovleva, I A ^b   Musteata, L Z ^a,b   Suharschii, I S ^b   Antoci, L T ^b  

^a STATE UNIVERSITY OF MEDICINE AND PHARMACY NICOLAE TESTEMITANU   (Moldova)

^b Institute of Oncology   (Moldova)

Author keywords

Chemotherapy; Low grade lymphoma of the spleen; Remission rate; Splenectomy; Survival

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; VINBLASTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY; CYTOPENIA; DISEASE DURATION; EVALUATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REMISSION; SPLEEN LYMPHOCYTE; SPLENECTOMY; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; LYMPHOMA, LOW-GRADE; MALE; MIDDLE AGED; SPLENECTOMY; SPLENIC NEOPLASMS;

EID: 10844221549     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2004.00641.x     Document Type: Article

References (20)

1. Berger F., Felman P., Thieblemont C., Pradier T., Baseggio L., Bryon P.A., Salles G., Callet-Bauchu E. & Coiffier B. (2000) Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 95, 1950-1956.
2. Brox A., Bishinsky J. & Berry G. (1991) Primary non-Hodgkin lymphoma of the spleen. American Journal of Hematology 38, 95-100.
3. Carbone P.P., Kaplan H.S., Musshoff K., Smithers D.W. & Tubiana M. (1971) Report of the Committee on Hodgkin's disease staging classification. Cancer Research 31, 1860-1861.
4. Catovsky D. & Matutes E. (1999) Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma. Seminars in Hematology 36, 148-154.
5. Chaćon J.I., Mollejo M., Muňoz E., Algara P., Mateo M., Lopez L., Andrade J., Carbonero I.G., Martinez B., Piris M.A. & Cruz M.A. (2002) Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients. Blood 100, 1648-1654.
6. Delpero J.R., Houvenaeghel G., Gastaut J.A., Orsoni P., Blache J.L., Guerinel G. & Carcassonne Y. (1990) Splenectomy for hypersplenism in chronic lymphocytic leukemia and malignant non-Hodgkin's lymphoma. British Journal of Surgery 77, 443-449.
7. European Organization for Research and Treatment of Cancer (1994) A Practical Guide to EORTC Studies, pp. 110-112. EORTC, Brussels, Belgium.
8. Falk S. & Stutte H.J. (1990) Primary malignant lymphomas of the spleen. A morphologic and immunohistochemical analysis of 17 cases. Cancer 66, 2612-2619.
9. Hauke R.J. & Armitage J.O. (2000) Treatment of non-Hodgkin lymphoma. Current Opinion in Oncology 12, 412-418.
10. Jaffe E.S., Harris N.L., Stein H. & Vardiman J.W (eds) (2001). Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, World Health Organization Classification of Tumours. IARC Press, Lyon, France, p. 120.
11. Kaplan E.L. & Meier P. (1958) Nonparametric estimation from incomplete observations. Journal of American Statistic Association 1860-1861.
12. Karnofsky P.A. & Burchenal J.H. (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: Evaluation of Chemotherapeutic Agents (ed. C.M. Macleod), p. 191. Columbia University Press, New York, NY, USA.
13. Kehoe J. & Straus D.J. (1988) Primary lymphoma of the spleen: clinical features and outcome after splenectomy. Cancer 62, 1433-1438.
14. Kraemer B.B., Osborne B.M. & Butler J.J. (1984) Primary splenic presentation of malignant lymphoma and related disorders: a study of 49 cases. Cancer 54, 1606-1619.
15. Morel P., Dupriez B., Gosselin B., Fenaux P., Estienne M.H., Facon T., Jouet J.P. & Bauters F. (1993) Role of early splenectomy in malignant lymphomas with prominent splenic involvement (primary lymphomas of the spleen). A study of 59 cases. Cancer 71, 207-215.
16. Mulligan S.P., Matutes E., Dearden C. & Catovsky D. (1991) Splenic lymhoma with villous lymphocytes: natural history and response to therapy in 50 cases. British Journal of Haematology 78, 206-209.
17. Schmid C., Kirkham N., Diss T. & Isaacson P.G. (1992) Splenic marginal zone cell lymphoma. The American Journal of Surgical Pathology 16, 455-466.
18. Spier C., Kjeldsberg C., Eyre H. & Behm F.G. (1985) Malignant lymphoma with primary presentation in the spleen. Archives of Pathology & Laboratory Medicine 109, 1076-1080.
19. Troussard X., Valensi F., Duchayne E., Garand R., Felman P., Tulliez M., Henry-Amar M., Bryon P.A. & Flandrin G. (1996) Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. British Journal of Haematology 93, 731-736.
20. World Health Organization (1979) WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication, Geneva.